Reply to Wilson et al.

Dickstein, Yaakov; Leibovici, Leonard; Carmeli, Yehuda; Daikos, George; Durante-Mangoni, Emanuele; Friberg, Lena E; Paul, Mical

Dickstein, Yaakov; Leibovici, Leonard; Carmeli, Yehuda; Daikos, George; Durante-Mangoni, Emanuele; Friberg, Lena E; Paul, Mical.

Afiliación

Dickstein Y; Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel.
Leibovici L; Sackler Faculty of Medicine, Tel Aviv University, Ramat-Aviv, Israel.
Carmeli Y; Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Daikos G; Sackler Faculty of Medicine, Tel Aviv University, Ramat-Aviv, Israel.
Durante-Mangoni E; National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel-Aviv, Israel.
Friberg LE; First Department of Medicine, Laikon General Hospital, Athens, Greece.
Paul M; National and Kapodistrian University of Athens, Athens, Greece.

Clin Infect Dis ; 71(5): 1358-1359, 2020 08 22.

Article en En | MEDLINE | ID: mdl-31734694

Asunto(s)

Acinetobacter baumannii; Colistina; Carbapenémicos; Humanos; Resultado del Tratamiento

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colistina / Acinetobacter baumannii Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2020 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google